Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMS-I Pharmacokinetics and Safety in Healthy Adults
NCT03026205Phase 2Withdrawn
- Sponsor
- University of Toledo Health Science Campus
- Start
- Jan 2017
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetylpyridinium chloride in viral upper respiratory tract infection, sponsored by University of Toledo Health Science Campus. Planned start Jan 2017; status: withdrawn.
02
Drugs
cetylpyridinium chloride
03
Conditions
viral upper respiratory tract infection
Beyond the preview
Go deeper on NCT03026205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026205.